Efficacy and Safety of Icotinib in Treating Non-Small Cell Lung Cancer: A Systematic Evaluation and Meta-Analysis Based on 15 Studies

Oncotarget - United States
doi 10.18632/oncotarget.13509
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Efficacy of EGFR-TKIs With or Without Angiogenesis Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Cancer
Oncology
2020English

Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2011English

Clinicopathological Significance of DAPK Promoter Methylation in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Cancer Management and Research
Oncology
2018English

Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Meta-Analysis of Efficacy and Adverse Events of Erlotinib-Based Targeted Therapies for Advanced/Metastatic Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Pcn44 - First-Line Treatment Efficacy in Egfr-Positive Non-Small Cell Lung Cancer: A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Observational Study on the Efficacy and Safety of Erlotinib in Patients With Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2012English

The Safety and Efficacy of Amrubicin in the Treatment of Previously Untreated Extensive-Disease Small-Cell Lung Cancer: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy